1661 - 1670 of 5832 Results
Title
Year
-
OPENTitle: Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 6Start Page: 1284End Page: 1289Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28986Citation Count: 6
- The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity2022OPENTitle: The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicityJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1083/jcb.202010065Best OA location URL: https://rupress.org/jcb/article-pdf/221/4/e202010065/1429684/jcb_202010065.pdfCitation Count: 15
-
OPENTitle: Aquaporin-4 Polymorphisms Are Associated With Cognitive Performance in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.740491Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.740491/pdfCitation Count: 24
- Characterisation of the Function of a SINE-VNTR-Alu Retrotransposon to Modulate Isoform Expression at the MAPT Locus2022OPENTitle: Characterisation of the Function of a SINE-VNTR-Alu Retrotransposon to Modulate Isoform Expression at the MAPT LocusJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2022.815695Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2022.815695/pdfCitation Count: 10
- Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease2022OPENTitle: Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson’s DiseaseJournal Name: SensorsPublisher: MDPI AGVol: 22Issue #: 6Start Page: 2136End Page: 2136Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s22062136Best OA location URL: https://www.mdpi.com/1424-8220/22/6/2136/pdf?version=1646901060Citation Count: 14
-
OPENTitle: Undetected ophthalmological disorders in Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 7Start Page: 3821End Page: 3832Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-022-11014-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-022-11014-0.pdfCitation Count: 12
-
OPENTitle: Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synucleinJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-07706-2Best OA location URL: https://www.nature.com/articles/s41598-022-07706-2.pdfCitation Count: 8
- Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration2022OPENTitle: Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2121609119Best OA location URL: https://doi.org/10.1073/pnas.2121609119Citation Count: 24
- Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population2022OPENTitle: Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK PopulationJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 4Start Page: 359End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0003Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2789505/jamaneurology_simonet_2022_oi_220001_1649435706.38428.pdfCitation Count: 47
- Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy2022OPENTitle: Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System AtrophyJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 5Start Page: 906End Page: 906Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11050906Best OA location URL: https://www.mdpi.com/2073-4409/11/5/906/pdf?version=1646555264Citation Count: 23